Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024

SELL
$14.85 - $19.04 $2,970 - $3,808
-200 Closed
0 $0
Q1 2022

Aug 14, 2024

BUY
$6.87 - $11.11 $1,374 - $2,222
200 New
200 $1.85 Million
Q4 2021

Aug 30, 2024

SELL
$7.7 - $37.13 $3,141 - $15,149
-408 Reduced 67.11%
200 $1.95 Million
Q2 2021

Aug 30, 2024

BUY
$32.73 - $47.95 $19,899 - $29,153
608 New
608 $22.3 Million
Q1 2021

Aug 30, 2024

BUY
$40.39 - $56.73 $16,479 - $23,145
408 New
408 $18.3 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.